Cadrenal Therapeutics Statistics

Total Valuation

CVKD has a market cap or net worth of $8.75 million. The enterprise value is $6.44 million.

Market Cap	8.75M
Enterprise Value	6.44M

Important Dates

The next estimated earnings date is Monday, August 10, 2026, before market open.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

CVKD has 2.87 million shares outstanding. The number of shares has increased by 50.99% in one year.

Current Share Class	2.87M
Shares Outstanding	2.87M
Shares Change (YoY)	+50.99%
Shares Change (QoQ)	+13.41%
Owned by Insiders (%)	15.48%
Owned by Institutions (%)	6.05%
Float	2.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.25
P/TBV Ratio	4.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.68

Current Ratio	2.68
Quick Ratio	2.17
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -300.59% and return on invested capital (ROIC) is -190.38%.

Return on Equity (ROE)	-300.59%
Return on Assets (ROA)	-139.24%
Return on Invested Capital (ROIC)	-190.38%
Return on Capital Employed (ROCE)	-670.38%
Weighted Average Cost of Capital (WACC)	13.13%
Revenue Per Employee	n/a
Profits Per Employee	-$2.38M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.10% in the last 52 weeks. The beta is 1.61, so CVKD's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	-70.10%
50-Day Moving Average	4.81
200-Day Moving Average	8.20
Relative Strength Index (RSI)	33.16
Average Volume (20 Days)	77,455

Short Selling Information

The latest short interest is 68,650, so 2.39% of the outstanding shares have been sold short.

Short Interest	68,650
Short Previous Month	70,928
Short % of Shares Out	2.39%
Short % of Float	2.83%
Short Ratio (days to cover)	1.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.05M
Pretax Income	-11.89M
Net Income	-11.89M
EBITDA	-12.05M
EBIT	-12.05M
Earnings Per Share (EPS)	-$5.57

Full Income Statement

Balance Sheet

The company has $2.31 million in cash and n/a in debt, giving a net cash position of $2.31 million or $0.80 per share.

Cash & Cash Equivalents	2.31M
Total Debt	n/a
Net Cash	2.31M
Net Cash Per Share	$0.80
Equity (Book Value)	1.80M
Book Value Per Share	0.72
Working Capital	1.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.96 million and capital expenditures -$1,853, giving a free cash flow of -$10.96 million.

Operating Cash Flow	-10.96M
Capital Expenditures	-1,853
Depreciation & Amortization	1,912
Net Borrowing	n/a
Free Cash Flow	-10.96M
FCF Per Share	-$3.82

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CVKD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.99%
Shareholder Yield	-50.99%
Earnings Yield	-135.90%
FCF Yield	-125.25%

Analyst Forecast

The average price target for CVKD is $27.67, which is 794.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$27.67
Price Target Difference	794.02%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Aug 20, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1